Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

GLP-1 patches for weight loss have made the scene—but a leading MD warns you they aren't the same as the more familiar ...

Photo credit: shutterstock.com/These trendy patches promise Ozempic-like results without the prescription but experts are skeptical If your social media feed is ...

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

Come prepared with the right questions and information about your goals, weight loss history, and diet and exercise plan to ...

New research reveals how GLP-1 medications are reshaping the treatment landscape for conditions affecting the heart, kidney, liver, and more, hinting at a new era in chronic disease management.

Endocrinologists, nutritionists, and personal trainers explain why it's important to stick to your workout routine when ...

GLP-1 drugs like Ozempic and Wegovy are transforming public health and consumer habits. Here we explore their explosive ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

GLP-1 receptor agonist therapy reduced surgical abscess repairs and hospitalizations among people with hidradenitis ...

To begin with, Sheer said to be honest about the outcome. “Tell the patient ‘Maybe’ and ‘We will try.’ Have a plan A and plan ...